Caliway Biopharmaceuticals Co., Ltd. (6919)
TWSE
Closed
Dec 2, 2024
Day's Range
592.0052 wk Range
240.50Profile - 6919 - Caliway Biopharmaceuticals Co., Ltd.
Profile
Mic Code
XTAI
Sector
Healthcare
Industry
Biotechnology
Employees
0
Caliway Biopharmaceuticals Co., Ltd. is a company specializing in the development and commercialization of innovative pharmaceutical products. Its primary function is to advance medical treatments through its robust pipeline of therapies, focusing on unmet medical needs in areas such as dermatology, neurology, and oncology. The biopharmaceutical firm aims to transform cutting-edge research into accessible healthcare solutions, with a particular emphasis on injectable treatments and small molecule drugs. Caliway Biopharmaceuticals operates within the highly dynamic and competitive biotechnology and pharmaceuticals sector, which is crucial for advancing medical science and improving patient outcomes. Its significant role in the market lies in its focus on innovation and addressing niche therapeutic areas, which can generate substantial benefits for the healthcare community as well as providing solutions that potentially improve quality of life. Headquartered in a strategic location with access to research facilities and partnerships, Caliway Biopharmaceuticals embodies a commitment to pushing the boundaries of modern medicine.
Profile Details
Type
Common Stock
Address
No.99, Xintai 5th Road
City
New Taipei City
Zip
221
Country
Taiwan
Phone
886 2 2697 1355
Key Executives - 6919 - Caliway Biopharmaceuticals Co., Ltd.
Key executives
Cross Listings - 6919 - Caliway Biopharmaceuticals Co., Ltd.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
